首页|期刊导航|Cancer Innovation|Epi‐Immunotherapy in Cancer Treatment:Mechanisms,Clinical Progress,and Future Directions

Epi‐Immunotherapy in Cancer Treatment:Mechanisms,Clinical Progress,and Future Directions

Nannan Lu Guanghua Rong Weidong Han

Cancer Innovation2025，Vol.4Issue(5)：P.26-49,24.

Cancer Innovation2025，Vol.4Issue(5)：P.26-49,24.DOI:10.1002/cai2.70023

Epi‐Immunotherapy in Cancer Treatment:Mechanisms,Clinical Progress,and Future Directions

Nannan Lu ¹Guanghua Rong ²Weidong Han³

作者信息

1. Department of Bio‐therapeutic,the First Medical Centre,Chinese PLA General Hospital,Beijing,China Department of Bio‐therapeutic,the Fifth Medical Centre,Chinese PLA General Hospital,Beijing,China
2. Department of Bio‐therapeutic,the Fifth Medical Centre,Chinese PLA General Hospital,Beijing,China
3. Department of Bio‐therapeutic,the First Medical Centre,Chinese PLA General Hospital,Beijing,China Changping Laboratory,Beijing,China
折叠

摘要

关键词

cancer/epigenetics/epi‐immunotherapy/immunotherapy/tumor immune evasion/tumor microenvironment

分类

医药卫生

引用本文复制引用

Nannan Lu,Guanghua Rong,Weidong Han..Epi‐Immunotherapy in Cancer Treatment:Mechanisms,Clinical Progress,and Future Directions[J].Cancer Innovation,2025,4(5):P.26-49,24.

基金项目

supported by the National Natural Science Foundation of China(82341208,82430012). （82341208,82430012）

Cancer Innovation

ISSN：2770-9191

访问量1

下载量0

段落导航